Cinven

What Cinven does

Cinven is a London-headquartered international private equity firm founded in 1977 that invests in high-performing businesses with strong growth potential across six core sectors: Business Services, Consumer, Financial Services, Healthcare, Industrials, and Technology, Media and Telecommunications (TMT). The firm operates primarily in Europe with selective North American activity, supported by offices in London, Paris, Frankfurt, Luxembourg, Madrid, Milan, and New York, and is dual-regulated by the UK Financial Conduct Authority and the Luxembourg Commission de Surveillance du Secteur Financier (CSSF). Cinven applies a proprietary matrix approach combining sector specialists with regional experts to source, evaluate, and manage investments, and works in close partnership with portfolio company management teams to execute value creation plans. Across fund vintages the firm has raised more than €50 billion, completed over 150 investments, holds 40+ portfolio companies, and has realised €52 billion in proceeds, with marquee outcomes including the €29.4 billion TK Elevator exit to Kone, the €4.25 billion MasOrange exit to Orange, and the $8.88 billion sale of Clario to Thermo Fisher Scientific.

Name

Cinven

Legal name

Cinven Limited

Website

https://cinven.com

Company type

Private

Founded year

1977

Operating status

Operating

Headcount range

51–100 employees

Short description

Cinven is a London-based international private equity firm founded in 1977 that invests across six core sectors (Business Services, Consumer, Financial Services, Healthcare, Industrials, TMT) in Europe and selectively North America, managing €50bn+ in funds raised across 150+ investments.

Ownership category

akta.pro rank

Product category

Private Equity Fund Management

NAICS

Portfolio Management and Investment Advice (523940), Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523)

SIC

Investment Advice (6282), Investors, Nec (6799)

akta.pro primary industry

Venture Debt Providers (FSANAAAL)

Keywords

• Private equity investments
• Buyout fund management
• Portfolio company value creation
• Institutional asset management
• Carve-out acquisitions

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Advisory Fees: Advisory fees charged to managers of Cinven's funds, calculated by reference to investor commitments during the fund's investment period.
2. Investment Management Fees: Investment management fees earned by the firm, calculated by reference to invested capital following the end of the fund's investment period. These are stable and predictable sources of income.
3. Carried Interest: Carried interest schemes where returns are wholly variable and determined by the underlying performance of the relevant fund.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Cinven is an international private equity firm that manages private equity funds investing in high-performing businesses with strong growth potential across six core sectors: Business Services, Consumer, Financial Services, Healthcare, Industrials, and TMT. The firm sources, executes, and manages buyout and growth investments, working closely with portfolio company management teams to deliver strategic and operational value creation, while earning revenue from advisory fees, investment management fees, and carried interest.

Product overview

Cinven is an international private equity firm managing approximately €50 billion in total funds raised and over 150 investments. The firm operates across six core sectors (Business Services, Consumer, Financial Services, Healthcare, Industrials, and TMT) and follows a partnership approach with portfolio company management. Cinven's portfolio includes software/technology companies (Archer - GRC software, Ongoing Warehouse - WMS, Taxwell - tax software), healthcare/life sciences companies (SYNLAB, LGC, Clario, Regenity Biosciences, Nutrisens, National Seating & Mobility), consumer brands (Vitamin Well Group, Kurt Geiger), and industrial/infrastructure companies (TK Elevator, Netceed, Accumin). The firm's value creation approach emphasizes thematic investing, sector expertise, and operational partnership with management teams across Europe and select North American markets.

Differentiator

Problem solved

Functional benefit

Brands

• Cinven Foundation: Corporate foundation focused on philanthropy and social responsibility initiatives
• Ongoing Warehouse
• Regenity Biosciences

Products and services

• Cinven Private Equity Funds
• Cinven Fund Management

Quantifiable outcome

• €52 billion in realised proceeds across 150+ investments
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature1 record

Partnerships

Three partnerships are on record, tiered core and minor.

• Ongoing Warehouse FounderscoreStrategic or Co-development Partner · 6 May 2026Cinven agreed to invest in Ongoing Warehouse alongside founders Henrik Ekman and Gerhard Guron, who remain significant shareholders. This represents the third investment from Cinven's new mid-market strategy.
• Flint GlobalminorStrategic or Co-development Partner · 8 December 2025Cinven agreed to acquire a majority stake in Flint Global, a professional services firm advising on regulatory and policy matters. The investment supports Flint's international expansion and practice diversification.
• Objectway Founder Luigi MarcianocoreStrategic or Co-development Partner · 29 August 2025Cinven made a majority investment in Objectway, a software provider for financial institutions, with Luigi Marciano remaining CEO and significant shareholder. The investment supports growth and technology development.

Scale indicators17 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• CVC Capital Partners: CVC is the most directly comparable European-headquartered private equity firm, similar vintage (1981), similar AUM scale (€150bn+), similar six-sector framework, and recently public. Direct competition in mid-to-large-cap European buyouts.
• Permira: Permira is a London-headquartered private equity firm founded in 1985, comparable to Cinven in European focus, mid-to-large-cap buyout size, and sector breadth (Consumer, Tech, Healthcare, Financial Services, Industrial Tech). Direct co-investor and competitor in European deals.
• EQT Partners: EQT is a Stockholm-based private equity firm with comparable European mid-to-large-cap focus and similar sector coverage, including recent involvement as seller of idealista to Cinven. Listed on Nasdaq Stockholm with ~€250bn AUM.
• Apax Partners: Apax is a London-headquartered private equity firm comparable to Cinven in European mid-to-large-cap buyouts across Technology, Services, Healthcare, and Consumer sectors, with similar fund size and vintage.
• BC Partners: BC Partners is a London-based private equity firm of similar vintage (1986) and European mid-to-large-cap focus. Direct peer in consumer, services, and industrial buyouts across Europe.
• Bridgepoint: Bridgepoint is a European mid-market private equity firm that previously owned Vitamin Well (sold to Cinven in 2024). Comparable mid-market European focus with overlap on consumer and services buyouts.
• Advent International: Advent is a long-standing co-investment partner of Cinven, jointly acquiring TK Elevator in 2020 and exiting together to Kone for €29.4bn in 2026. Boston-headquartered but globally active with strong European presence, making it a directly comparable peer and frequent consortium partner.

Broad incumbents

• Bain Capital: Bain Capital is a Boston-headquartered global private equity firm with comparable scale, sector breadth, and prior co-investment with Cinven (Stada joint venture exited to CapVest). Functions as both a co-investor and broader incumbent across Cinven's sectors.
• KKR: KKR is a global incumbent private equity firm and long-standing co-investment partner with Cinven, jointly owning MasOrange (acquired in 2020 and exited in 2026 for €4.25bn) and partnering on MasMovil. Broader and more globally diversified than Cinven but directly comparable in scale and sector reach.
• The Carlyle Group: Carlyle is a global incumbent private equity firm with comparable AUM and sector breadth, and a former seller of Euro Techno Com Group to Cinven. Broader geographic footprint than Cinven but directly comparable in European large-cap buyout activity.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/cinven

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Subsidiaries10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A79 records

Investments16 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cinven